1
NAMS Menopause Certification Exam (MSCP)
2026/2027 Questions and Answers.
Q1. According to the STRAW+10 staging system, what is the primary criterion for
defining the onset of the late menopausal transition?
A. The occurrence of a missed period followed by amenorrhea of 60 days or more.
B. Elevated follicle-stimulating hormone (FSH) levels greater than 40 IU/L on two
occasions. [CORRECT]
C. The presence of vasomotor symptoms and cycle irregularity.
Correct Answer: B
Rationale: The STRAW+10 criteria define the late menopausal transition stage
primarily by elevated FSH levels (typically >25 IU/L, but persistently rising), often
characterized by amenorrhea of 60+ days or skipped cycles. Option A is part of the
clinical window but the hormonal criterion is key for staging; Option C describes
symptoms which are subjective and not diagnostic markers.
Q2. Which hormone is the most sensitive and reliable early marker of diminishing
ovarian reserve in women over 35?
A. Follicle-stimulating hormone (FSH).
B. Inhibin B. [CORRECT]
C. Estradiol.
Correct Answer: B
Rationale: Inhibin B decreases earlier in the process of ovarian aging than FSH rises
or estradiol fluctuates, making it a sensitive marker of declining follicle count and
reserve in early perimenopause. FSH rises later as negative feedback weakens;
estradiol levels remain variable and are not reliable early markers.
Q3. What characterizes the hormonal milieu of the early postmenopausal stage?
A. Estrogen levels are slightly elevated while progesterone remains stable.
B. Estrogen is consistently low, and inhibin is undetectable. [CORRECT]
,2
C. FSH levels return to premenopausal ranges due to ovarian senescence.
Correct Answer: B
Rationale: In the early postmenopausal stage, the ovaries have ceased significant
follicular activity, resulting in consistently low estradiol and undetectable inhibin
levels. FSH remains permanently elevated due to the loss of negative feedback; it
does not return to premenopausal ranges.
Q4. A 32-year-old woman presents with secondary amenorrhea and hot flashes.
Laboratory evaluation reveals FSH of 45 IU/L and estradiol of 20 pg/mL. Which
condition is indicated?
A. Hypothalamic amenorrhea.
B. Premature Ovarian Insufficiency (POI). [CORRECT]
C. Polycystic Ovary Syndrome (PCOS).
Correct Answer: B
Rationale: POI is defined by the loss of ovarian function before age 40, characterized
by amenorrhea, elevated FSH (>25-30 IU/L), and hypoestrogenism. Hypothalamic
amenorrhea typically presents with low or normal FSH; PCOS presents with
oligomenorrhea and normal/low FSH.
Q5. During the menopausal transition, the luteal phase shortens due to which
mechanism?
A. Decreased sensitivity of the hypothalamus to estrogen.
B. Accelerated follicular recruitment and earlier ovulation. [CORRECT]
C. Increased progesterone receptor sensitivity in the endometrium.
Correct Answer: B
Rationale: The shortening of the luteal phase in the menopausal transition is
primarily due to a shorter follicular phase leading to earlier ovulation, resulting in a
corpus luteum that is less functional and regresses prematurely. This is distinct from
hypothalamic sensitivity changes which occur later.
,3
Q6. What is the primary source of androgens (testosterone and androstenedione) in
postmenopausal women?
A. The ovaries.
B. The adrenal glands. [CORRECT]
C. Peripheral adipose tissue conversion.
Correct Answer: B
Rationale: While the ovaries continue to produce some androgens postmenopause,
the adrenal glands become the primary source of circulating androgens
(androstenedione and DHEA), which are then peripherally converted to testosterone
and estrogens. Adipose tissue contributes to conversion but is not the primary
source of production.
Q7. Which change in lipid profile is most commonly associated with the decline in
endogenous estrogen during menopause?
A. Decrease in total cholesterol and LDL-C.
B. Increase in LDL-C and total cholesterol. [CORRECT]
C. Increase in HDL-C and decrease in triglycerides.
Correct Answer: B
Rationale: The loss of estrogen's cardioprotective effects leads to an unfavorable
lipid shift, characterized by an increase in low-density lipoprotein cholesterol (LDL-
C) and total cholesterol. HDL-C typically decreases or remains stable, while
triglycerides often rise.
Q8. In the context of the hypothalamic-pituitary-ovarian (HPO) axis during
perimenopause, what causes the initial rise in FSH?
A. Pituitary hyperplasia.
B. Decreased inhibin A and B production from the ovary. [CORRECT]
C. Increased GnRH pulse frequency solely.
Correct Answer: B
, 4
Rationale: The earliest hormonal change is a decline in inhibin A and B (produced by
developing follicles), which removes the negative feedback on the pituitary, leading
to a selective rise in FSH before significant changes in estradiol or GnRH pulse
frequency occur.
Q9. What defines the "Climacteric" phase?
A. The 12 months following the final menstrual period.
B. The transitional period covering the perimenopausal and early postmenopausal
years. [CORRECT]
C. The onset of menstrual irregularity in the late reproductive years.
Correct Answer: B
Rationale: The climacteric is a broader term referring to the entire transitional
period including the time before, during, and after the menopause (cessation of
menses), encompassing the endocrine and biological shifts.
Q10. A 48-year-old woman reports cycles shortening from 28 days to 21 days. This is
indicative of which stage?
A. Late postmenopause.
B. Early menopausal transition. [CORRECT]
C. Premature Ovarian Insufficiency.
Correct Answer: B
Rationale: A shortening of the menstrual cycle by more than 7 days is the hallmark of
the Early Menopausal Transition (Stage -2 per STRAW+10), driven by a shortened
follicular phase.
Q11. Which ovarian reserve test measures the number of primordial follicles
remaining?
A. Day 3 FSH.
B. Antral Follicle Count (AFC). [CORRECT]
C. Serum progesterone.
NAMS Menopause Certification Exam (MSCP)
2026/2027 Questions and Answers.
Q1. According to the STRAW+10 staging system, what is the primary criterion for
defining the onset of the late menopausal transition?
A. The occurrence of a missed period followed by amenorrhea of 60 days or more.
B. Elevated follicle-stimulating hormone (FSH) levels greater than 40 IU/L on two
occasions. [CORRECT]
C. The presence of vasomotor symptoms and cycle irregularity.
Correct Answer: B
Rationale: The STRAW+10 criteria define the late menopausal transition stage
primarily by elevated FSH levels (typically >25 IU/L, but persistently rising), often
characterized by amenorrhea of 60+ days or skipped cycles. Option A is part of the
clinical window but the hormonal criterion is key for staging; Option C describes
symptoms which are subjective and not diagnostic markers.
Q2. Which hormone is the most sensitive and reliable early marker of diminishing
ovarian reserve in women over 35?
A. Follicle-stimulating hormone (FSH).
B. Inhibin B. [CORRECT]
C. Estradiol.
Correct Answer: B
Rationale: Inhibin B decreases earlier in the process of ovarian aging than FSH rises
or estradiol fluctuates, making it a sensitive marker of declining follicle count and
reserve in early perimenopause. FSH rises later as negative feedback weakens;
estradiol levels remain variable and are not reliable early markers.
Q3. What characterizes the hormonal milieu of the early postmenopausal stage?
A. Estrogen levels are slightly elevated while progesterone remains stable.
B. Estrogen is consistently low, and inhibin is undetectable. [CORRECT]
,2
C. FSH levels return to premenopausal ranges due to ovarian senescence.
Correct Answer: B
Rationale: In the early postmenopausal stage, the ovaries have ceased significant
follicular activity, resulting in consistently low estradiol and undetectable inhibin
levels. FSH remains permanently elevated due to the loss of negative feedback; it
does not return to premenopausal ranges.
Q4. A 32-year-old woman presents with secondary amenorrhea and hot flashes.
Laboratory evaluation reveals FSH of 45 IU/L and estradiol of 20 pg/mL. Which
condition is indicated?
A. Hypothalamic amenorrhea.
B. Premature Ovarian Insufficiency (POI). [CORRECT]
C. Polycystic Ovary Syndrome (PCOS).
Correct Answer: B
Rationale: POI is defined by the loss of ovarian function before age 40, characterized
by amenorrhea, elevated FSH (>25-30 IU/L), and hypoestrogenism. Hypothalamic
amenorrhea typically presents with low or normal FSH; PCOS presents with
oligomenorrhea and normal/low FSH.
Q5. During the menopausal transition, the luteal phase shortens due to which
mechanism?
A. Decreased sensitivity of the hypothalamus to estrogen.
B. Accelerated follicular recruitment and earlier ovulation. [CORRECT]
C. Increased progesterone receptor sensitivity in the endometrium.
Correct Answer: B
Rationale: The shortening of the luteal phase in the menopausal transition is
primarily due to a shorter follicular phase leading to earlier ovulation, resulting in a
corpus luteum that is less functional and regresses prematurely. This is distinct from
hypothalamic sensitivity changes which occur later.
,3
Q6. What is the primary source of androgens (testosterone and androstenedione) in
postmenopausal women?
A. The ovaries.
B. The adrenal glands. [CORRECT]
C. Peripheral adipose tissue conversion.
Correct Answer: B
Rationale: While the ovaries continue to produce some androgens postmenopause,
the adrenal glands become the primary source of circulating androgens
(androstenedione and DHEA), which are then peripherally converted to testosterone
and estrogens. Adipose tissue contributes to conversion but is not the primary
source of production.
Q7. Which change in lipid profile is most commonly associated with the decline in
endogenous estrogen during menopause?
A. Decrease in total cholesterol and LDL-C.
B. Increase in LDL-C and total cholesterol. [CORRECT]
C. Increase in HDL-C and decrease in triglycerides.
Correct Answer: B
Rationale: The loss of estrogen's cardioprotective effects leads to an unfavorable
lipid shift, characterized by an increase in low-density lipoprotein cholesterol (LDL-
C) and total cholesterol. HDL-C typically decreases or remains stable, while
triglycerides often rise.
Q8. In the context of the hypothalamic-pituitary-ovarian (HPO) axis during
perimenopause, what causes the initial rise in FSH?
A. Pituitary hyperplasia.
B. Decreased inhibin A and B production from the ovary. [CORRECT]
C. Increased GnRH pulse frequency solely.
Correct Answer: B
, 4
Rationale: The earliest hormonal change is a decline in inhibin A and B (produced by
developing follicles), which removes the negative feedback on the pituitary, leading
to a selective rise in FSH before significant changes in estradiol or GnRH pulse
frequency occur.
Q9. What defines the "Climacteric" phase?
A. The 12 months following the final menstrual period.
B. The transitional period covering the perimenopausal and early postmenopausal
years. [CORRECT]
C. The onset of menstrual irregularity in the late reproductive years.
Correct Answer: B
Rationale: The climacteric is a broader term referring to the entire transitional
period including the time before, during, and after the menopause (cessation of
menses), encompassing the endocrine and biological shifts.
Q10. A 48-year-old woman reports cycles shortening from 28 days to 21 days. This is
indicative of which stage?
A. Late postmenopause.
B. Early menopausal transition. [CORRECT]
C. Premature Ovarian Insufficiency.
Correct Answer: B
Rationale: A shortening of the menstrual cycle by more than 7 days is the hallmark of
the Early Menopausal Transition (Stage -2 per STRAW+10), driven by a shortened
follicular phase.
Q11. Which ovarian reserve test measures the number of primordial follicles
remaining?
A. Day 3 FSH.
B. Antral Follicle Count (AFC). [CORRECT]
C. Serum progesterone.
